Drug interactions
Ezetimibe + Zavegepant intranasal
Severity: Minor
Ezetimibe and Zavegepant intranasal: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Zavegepant is an NTCP substrate, and ezetimibe is not an established clinically relevant NTCP inhibitor. A meaningful rise in zavegepant exposure is not expected.
What this interaction means in plain words
Ezetimibe and Zavegepant intranasal have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Theoretical NTCP inhibition; not established as clinically relevant.
What to do
No dose adjustment is needed. Monitor for the usual zavegepant adverse effects.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Ezetimibe and Zavegepant intranasal, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Ezetimibe
- Apalutamide + Ezetimibe Moderate
- Cholestyramine + Ezetimibe Moderate
- Cyclosporin + Ezetimibe Moderate
- Ezetimibe + Gemfibrozil Moderate
- Ezetimibe + Glecaprevir / pibrentasvir Moderate
- Ezetimibe + Letermovir Moderate
Frequently asked questions
Can I take Ezetimibe with Zavegepant intranasal?
MediHelp rates the interaction as minor. Ezetimibe and Zavegepant intranasal have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Zavegepant is an NTCP substrate, and ezetimibe is not an established clinically relevant NTCP inhibitor. A meaningful rise in zavegepant exposure is not expected.
How serious is the interaction between Ezetimibe and Zavegepant intranasal?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is needed. Monitor for the usual zavegepant adverse effects.
What other medicines interact with Ezetimibe?
MediHelp also lists interactions of Ezetimibe with, for example, Apalutamide, Cholestyramine, Cyclosporin. The full list is on the Ezetimibe page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
